Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
844 0 |
SM ISO690:2012 CARPENCO, Ecaterina, CEAUSU, Amalia-Raluca, CIMPEAN, Anca-Maria, GAJE , Puşa Nela, ŞAPTEFRAŢI, Lilian, FULGA, Veaceslav, DAVID, Valeriu, RAICA, Marius. Mast cells as an indicator and prognostic marker in molecular subtypes of breast cancer. In: In Vivo, 2019, nr. 3(33), pp. 743-748. ISSN 0258-851X. DOI: https://doi.org/10.21873/invivo.11534 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
In Vivo | |
Numărul 3(33) / 2019 / ISSN 0258-851X | |
|
|
DOI:https://doi.org/10.21873/invivo.11534 | |
Pag. 743-748 | |
Rezumat | |
Background/Aim: Mast cells (MCs) represent the most controversial non-malignant element of the tumor microenvironment. Our aim was to study how MCs density and distribution (intratumoral-MCit versus peritumoral-MCpt) relate to tumor grade and molecular subtypes. Materials and Methods: MCs tryptase immunohistochemistry was performed on 80 cases of breast carcinomas. Results: For Luminal A tumors, a partial correlation was detected between MCit and progesterone receptor (PR) (p=0.005). Luminal B tumors showed a significant correlation between MCpt and age (p=0.009), estrogen receptor (ER) (p=0.017) and PR (p=0.035). MCit and MCpt were strongly interrelated in this subtype (p=0.002) and in triple-negative breast cancers (p=0.002). In HER2 subtype, MCpt tumors were significantly correlated with HER2 (p=0.044). In G2 tumors, MCpt correlated with ER (p=0.015) and PR (p=0.038) while in G3 tumors ER correlated with both MCit (p=0.009) and MCpt (p=0.000487) tumors. Conclusion: MCs dynamics are strongly influenced by hormone receptors and HER2 status. MCit increased in aggressive tumor types and is a worse prognostic factor. |
|
Cuvinte-cheie breast cancer, Hormone receptors, mast cell, prognosis, Tryptase, Tumor grade |
|
|